Tamara Baxter
Family · Palatka, FLNPI 1710331665
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AstraZeneca at 32.7% of the total. Reporting peaked in 2023 at $1,189 and has fallen 86.7% since, to $158 in 2025.
Across 157 payments — averaging $20.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$595
- Boehringer Ingelheim$328
- Amgen$283
- Insmed, Inc.$163
- Regeneron Healthcare Solutions, Inc.$157
- plus $605 from 12 others
What the payments were for
- Food & beverage$3,167100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 54 | $1,035 |
| GSK | 35 | $595 |
| Boehringer Ingelheim | 17 | $328 |
| Amgen | 12 | $283 |
| Insmed, Inc. | 7 | $163 |
| Regeneron Healthcare Solutions, Inc. | 7 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $131 |
| Sanofi | 4 | $120 |
| Novo Nordisk | 3 | $73 |
| Vapotherm Inc | 2 | $52 |
| Philips North America LLC | 1 | $46 |
| Inogen, Inc. | 2 | $38 |
| Pulmonx Corporation | 2 | $34 |
| Exact Sciences | 2 | $33 |
| Sunovion Pharmaceuticals Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$115
How this compares
$3,167 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 221 | $212,432 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 54 | $48,559 |
| Breo ElliptaFluticasone/Vilanterol | 37 | $20,864 |
| SymbicortBudesonide/Formoterol Fumarate | 29 | $16,201 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 20 | $15,631 |
| EliquisApixaban | 13 | $15,174 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 140 | $5,478 |
| Ventolin HfaAlbuterol Sulfate | 26 | $2,250 |
| Omeprazole | 61 | $1,295 |
| Montelukast Sodium | 68 | $973 |
| Losartan Potassium | 45 | $734 |
| Fluticasone Propionate | 32 | $665 |
| Levothyroxine Sodium | 43 | $605 |
| Atorvastatin Calcium | 47 | $603 |
| Gabapentin | 32 | $602 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $595 | $248,927278 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,035 | $64,76083 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 14,618 family providers in Florida.
Other family in Palatka
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.